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Papain digestion of mammalian immunoglobulin (Ig) results in the production of 
an  Fc  fragment  which  has  the  ability  to  activate  thymus-derived  (T)  and  bone 
marrow-derived  (B)cells.  Murine  B  ceils  are  induced  to  proliferate  (1-3)  and 
differentiate to polyclonal antibody-secreting cells  (4) in the presence of Fc fragments. 
The Fc fragment-induced activation of B cells requires accessory macrophages (2-4) 
and T  cells  (4).  Macrophages function by enzymatically digesting the Fc fragments 
into mitogenic subfragments which are responsible for inducing B cells to proliferate 
(3, 5). Fc fragments activate T  cells  (4, 6, 7) to secrete a soluble T  cell-replacing factor 
[(Fc)TRF]  1 (7), which in conjunction with Fc subfragment, induces the proliferating 
ceils to differentiate to antibody-producing cells. 
In addition to being a  potent polyclonal activator, Fc fragments possess  adjuvant 
properties  (8,  9).  Specific in  vivo and  in  vitro antibody responses  are enhanced by 
both homologous and heterologous Fc fragments. The adjuvant effect was found to 
be antigen-dose dependent, with the greatest enhancement occurring with suboptimal 
concentrations  of antigen.  T  cells  are  the  cell  population  through  which  the  Fc- 
adjuvant effect occurs (9). This was deduced from the fact that only thymus-dependent 
antibody responses could be enhanced. Moreover, when interleukin-2 was substituted 
for T  cells,  no enhancement was observed.  Because the  Fc fragment-mediated en- 
hancement of specific antibody response appears to occur through the helper T  cell 
population, it was of interest to determine whether other T cell responses were affected 
by Fc fragments. The studies in this report reveal that Fc fragments can potentiate T 
cell-mediated responses such as antigen-induced proliferation  and allogeneic mixed 
lymphocyte culture (MLC) responses. Enhancement of the MLC response occurs only 
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when differences between effector and stimulator populations encompass the I-A and/ 
or I-B subregions. 
Materials and Methods 
Animals.  Male mice of the C57BL/6 and CBA/CaJ strains were obtained from The Jackson 
Laboratory, Bar Harbor, Maine. Male mice of the A.TH, A.TL, A.AL, B10, B10.Br,  B10.A, 
B 10.A(2R),  B10.A(4R), and B10.A(5R)  were obtained from the Scripps Clinic and Research 
Foundation breeding colony, La Jolla, Calif. The major histocompatibility (H-2)  types of all 
strains used are shown in Table I. 
Preparation of Fc Fragments.  A human IgG1 myeloma protein (Fi) was a gift from Dr. Hans 
L. Spiegelberg, Scripps Clinic and Research Foundation. The IgG1 was purified by ammonium 
sulfate fractionation followed by  DEAE-eellulose chromatography with  0.01 M  phosphate 
buffer, pH 8, used as the eluent. Fc fragments were obtained by digestion of IgG1 with papain 
(Sigma Chemical Co., St. Louis, Mo.) in the presence of L-cysteine (Sigma Chemical Co.) and 
EDTA (J. T. Baker Chemical Co., Phillipsburg, N. J.) for 5 h (10). After digestion, the material 
was chromatographed on Sephadex G-100 to remove any undigested IgG. The Fc and Fab 
fragments were  then  separated  from  each  other  by  DEAE  chromatography  (11). The  Fc 
preparation was found not to be contaminated with endotoxin as described previously (2). 
Enrichment of T Cells.  T cells were enriched from whole spleen or lymph node preparations 
by filtration through nylon wool columns (Fenwall Laboratories, Fairfield, Ill.) (12). Contam- 
ination of the nylon wool-filtered cells with B cells was monitored by the mitogenic response to 
bacterial lipopolysaceharide. 
Antisera Treatment.  Antisera and complement (C')  treatment was performed essentially as 
recommended by Shen et  al.  (13). 50  ×  l0  s ceils/ml were  incubated with  an appropriate 
amount of antisera at 4°C for 30 min. The cells were washed with phosphate-buffered saline 
(PBS) containing 5% fetal calf serum (FCS)  (Grand Island Biological Co., Grand Island, N. Y.) 
and resuspended in RPMI-1640 (Flow Laboratories, Inc., Roekville, Md.) containing 5% FCS, 
1% sodium azide, and 25% C' in which they were incubated 30 min at 37"C. The C', a mixture 
of rabbit and guinea pig (Pel-Freeze Biologicals  Inc., Rogers, Ark.)  shown to be noncytotoxic 
for murine lymphoeytes, was a gift from Dr. Sharyn M. Walker, Scripps Clinic and Research 
Foundation. After C' treatment, the cells were washed in PBS with 5% FCS and resuspended 
in complete media. Anti-Lyt-1.2 and anti-Lyt-2.2 were obtained from Dr. F. W. Shen, Memorial 
Sloan-Kettering Cancer Center, New York. Under the conditions employed, 20-30% of spleen 
cells treated were recovered after Ly antisera and C' treatment. 
Antigen-induced T  Cell Proliferation.  To  obtain  primed T  cells,  ovalbumin (OVA)  (Miles 
Laboratories, Inc., Elkhart, Ind.) was emulsified in complete Freund's adjuvant (Difco Labo- 
ratories, Detroit, Mich.) and 50 #1 containing 100 #g antigen was injected subcutaneously at 
the base of the tail. Inguinal lymph nodes were removed 7-9 days postinjection and used for 
the in vitro stimulation. The lymph node proliferation assay was done according to the method 
of Corradin et  al.  (14). Briefly,  the inguinal lymph nodes were dissociated into a  single cell 
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glutamine, 1% BME vitamins (Grand Island Biological Co.), 100 U penicillin, 100 #g strepto- 
mycin (Microbiological Associates,  Walkersville, Md.),  5  X  10  -5 M  2-mercaptoethanol, and 
10% FCS were cultured with OVA in 0.3 ml final vol in flat-bottomed microtiter plates (3040 
Micro Test II; Falcon Labware, Div. of Beeton, Dickinson & Co., Oxnard, Calif.) for 5 d at 
37°C in an atmosphere of 5% CO2. The amount of proliferation was assessed by incorporation 
of 1 #Ci of [nH]thymidine (New England Nuclear, Boston, Mass.)  during a 24-h pulse. 
Induction of Primary MLC.  T  cell-enriched responder spleen cells  (2.5 ×  105) were cultured 
with various numbers of irradiated  (2,000  rad)  (Gamma Cell 40  Small Animal Irradiator; 
Atomic Energy of Canada Ltd., Ottawa, Canada) stimulator spleen cells at 37°C in 5% CO2 in 
a  final vol of 0.3  ml in flat-bottomed microtiter plates  (3040  Micro Test  II). The culture 
medium consisted  of  RPMI-1640  (Flow  Laboratories)  supplemented as  described  for  the 
antigen-induced proliferation. Unless otherwise stated, the cultures received 1 pCi [3H]thymi- 
dine (New England Nuclear) on day 3 and were harvested for scintillation counting on day 4. 
Data Analysis.  The enhancement index is a term used to describe the adjuvant properties of 
Fc fragments and is defined as the following: 
counts per minute (Fe +  antigen or stimulator cells) 
enhancement index = 
counts per minute (antigen or stimulator cells) 
Each  experiment  was  performed  a  minimum of  three  times  and  the  results  shown  are 
representative of all the data. 
Results 
Fc Fragment-mediated Enhancement of the Antigen-induced  Proliferative Response.  It  was 
previously shown that Fc fragments are capable of potentiating both in vivo and in 
vitro specific antibody responses (8, 9). To determine if the Fc adjuvant activity could 
be extended to  T  cell-mediated responses, the  antigen-induced T  cell proliferative 
response  was  assessed.  The  results  in  Fig.  1  indicate that  Fc  fragments  have  the 
capacity to enhance antigen-induced  proliferative responses. The maximum enhance- 
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Fro.  I.  Nylon wool-purified, lymph node-derived T cells were cultured with increasing amounts 
of OVA with or without  100 /~g/culture Fc. The response was measured on day 5 of culture. 
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ment(-- 17-fold)  occurred when suboptimal  concentrations of OVA were employed. 
That  this enhancement  was a  result  of T  cell  proliferation  is concluded because the 
lymph node cells used were nylon wool nonadherent and did not respond to bacterial 
lipopolysaccharide,  a  B cell mitogen (data not shown). Fc fragments were found not 
to directly induce T  cells to proliferate (Table III) as described previously (1). 
It has previously been reported  that  the  lymph node-derived  T  cell which prolif- 
erates to antigen belongs to the Lyt-l+23  -  subclass  (15). To confirm this observation 
in the present  model, nylon wool-purified lymph node cells from OVA-primed mice 
were treated  with anti-Lyt-l.2 or Lyt-2.2 before stimulation  with antigen.  Anti-Lyt- 
1.2 treatment of the lymph node cells before stimulation totally removed their ability 
to respond to OVA, whereas the cell population treated with anti-Lyt-2.2 responded 
as well as or better than the untreated control  (Table II). To determine whether the 
T  cell  population  affected  by  Fc  fragments  was  the  same  Lyt  phenotype  as  the 
population which proliferated  in response to antigenic stimulation,  the lymph node 
cells were treated  with anti-Lyt-l.2 before culturing.  The results reveal that  the Fc- 
induced  enhancement  (threefold)  disappeared  when  the  cells  were  depleted  of the 
Lyt-1+23  -  subpopulation  (Table III). In the reciprocal experiment, prior treatment of 
the  lymph  node  cells  with  anti-Lyt-2.2  resulted  in  no  effect  on  the  Fc-mediated 
enhancement  of T  cell proliferation  (Table IV). 
Fc Fragment-mediated Enhancement of the PrimaTy MLC.  To further explore the T  cell- 
adjuvant  potential  of Fc  fragments,  experimentation  was  conducted  to  ascertain 
whether Fc could enhance the primary allogeneic MLC. The results described in Fig. 
2 indicate that  the primary MLC between  C57BL/6 and CBA/CaJ spleen cells was 
enhanceable  by  Fc  fragments.  Optimal  enhancement  (16-fold)  occurred  with  a 
suboptimal  effector  to  stimulator  (E:S)  ratio.  When  the  cell  ratio  was  such  that 
maximal  proliferation  was  observed,  Fc  fragments  had  only  a  minimal  effect.  In 
addition, Fc fragments had no effect on the effector cell population in the absence of 
allogeneic  stimulator  cells  because  the  addition  of irradiated  syngeneic stimulators 
along with Fc produced no enhancement. To determine if the Fc-mediated potentia- 
tion was a  result of a  shift in the kinetics of the responses, cultures were assayed over 
a  6-d  period.  The presence  of Fc fragments  had  no significant  effect on the kinetic 
pattern of the MLC reaction (Fig. 3). Moreover, Fc fragments enhanced the response 
over the entire culture period. 
Major Histocompatibility Complex Difference Requirements to Observe Fc Fragment Enhance- 
TABLE  II 
Ly Phenotype of the Lymph Node T Cells Proliferating to 0 VA 
Treatment*  OVA  [aH]TdR uptake:~ 
I~g/  culture  c  pm/  culture 
None  --  2,153 4- 126 
None  100  31,872 4- 1,325 
Anti-Ly-l.2 + C'  --  4,082 4- 681 
Anti-Ly-l.2 + C'  100  7,214 4- 830 
Anti-Ly-2.2 + C'  -  2,915 4- 106 
Anti-Ly-2.2 + C'  100  69,592 +  1,873 
* Nylon wool-filtered lymph node cells were treated with either anti-Ly-1.2 or 
anti-Ly-2.2 + C' before stimulation with OVA. 
:~ The response was measured on day 5 of culture. E.  L.  MORGAN,  M.  L.  THOMAN,  AND  W.  O.  WEIGLE  1165 
TABLE  III 
Inability of Fc Fragments  to Enhance  OVA-induced Proliferation in Cultures 
Depleted of Ly-1 + T  Cells 
Enhancement  Treatment*  OVA  Fc  [3H]TdR uptake~  index§ 
ttg/culture  cpm/culture  ±  SE 
None  --  --  3,805 ±  33 
None  10  --  6,263 ±  712 
None  --  100  2,844 ±  305 
None  10  100  19,382 ±  932 
Anti-Ly-l.2 +  C'  --  --  4,911 ±  352 
Anti-Ly-l.2 +  C'  10  --  5,719 ±  1,422 
Anti-Ly-l.2 +  C'  --  100  3,613 +  238 
Anti-Ly-l.2 +  (3'  10  100  3,246 ±  1,363 
* Nylon wool-filtered lymph node cells were treated with nothing or anti-Ly- 
1.2 +  C' before stimulation with OVA. 
The response was measured on day 5 of culture. 
counts per minute (Fe +  OVA) 
§ Enhancement index 
counts per minute (OVA) 
TABLE  IV 
Ability of Fc Fragments  to Enhance  OVA-induced Proliferation in Cultures 
Depleted of Ly-23  + T  Cells 
Enhancement  Treatment*  OVA  Fc  [3H]TdR uptake~  index§ 
~g/culture  cpm/culture  ±  SE 
None  --  --  3,580 ±  549 
None  t0  --  12,385 +  779 
None  --  100  2,906 ±  502 
None  10  100  69,607  ±  7,124  6 
Anti-Ly-2.2 +  C'  --  --  1,809 ±  39 
Anti-Ly-2.2 +  (3'  10  --  7,109 :lz 169 
Anti-Ly-2.2 +  C'  --  100  2,231 ±  3,317 
Anti-Ly-2.2 +  C'  10  100  77,996 ±  3,630  11 
* Nylon wool-filtered lymph node cells were treated with nothing or anti-Ly- 
2.2 +  C' before stimulation with OVA. 
:~ The response was measured on day 5 of culture. 
counts per minute (Fc +  OVA) 
§ Enhancement index -~ 
counts per minute (OVA) 
ment  of the  MLC.  It  has  been  reported  in  the  literature  that,  depending  upon  the 
major  histocompatibility  complex  (H-2)  difference  between  effector  and  stimulator 
cells, different T  cell subsets are stimulated  to proliferate. The  data  expressed in Figs. 
2  and  3  were  obtained  from  C57BL/6  (H-2  d)  and  CBA/CaJ  (H-2  k)  mice  which 
differed at the H-2  locus as well as at minor  histocompatibility  loci. To  determine  if 
H-2 differences play a  role in Fc-induced  enhancement,  limited  H-2 differences were 
assessed  in generation  of MLC.  The  results in Fig.  4  indicate that  a  difference in the 
I-A and/or  I-B subregion  between  effector and  stimulator  cells is essential  to obtain 
an enhanced  MLC.  This was  deduced  from  the fact  that  only in experiments  where 
I-A  and/or  I-B  differences  were  present  (groups  I,  IV,  V,  VI,  and  VII)  did  Fc 
fragments enhance  the primary  MLC.  The I-region haplotype  did not appear  to make 1166  Fc-MEDIATED  ENHANCEMENT  OF  T  CELL  FUNCTIONS 
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FIc.  2.  Nylon wool-purified C57BL/6 splenic T  cells  were cultured  with  increasing numbers  of 
irradiated CBA/CaJ spleen cells with or without 100 #g/culture Fc. The response was measured on 
day 4 of culture. 
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FzG.  3.  Allogeneic MLC  response between C57BL/6  (responder) and CBA/CaJ  (stimulator cell 
populations). Suboptimal numbers (I  X  104/cuhure) of stimulator cells,  with or without  100 #g/ 
culture Fc, were added to 2.5 ×  l0  b responder cells and the response measured on day 4 of culture. 
a  difference  because  the A.TH  anti-A.TL  MLC  (group  IV)  recognized  I k  and  the 
B10.A  anti-B10.A(5R)  (group  V),  B10.A  anti-B10  (group  VI),  and  B10.Br  anti- 
B10.A(4R)  (group VII)  all  recognized I-A  b and/or I-B b.  The  Fc-mediated  enhance- 
ment of the MLC was not a result of the inability of the other groups to produce an 
MLC  because  in  all  cases,  optimal  E:S  ratios  produced  a  proliferative  response E.  L.  MORGAN, M.  L.  THOMAN,  AND W. O.  WEIGLE 
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Fie. 4.  Allogeneic  MLC responses  between mouse  strains with limited H-2 differences. Suboptimal 
numbers (1 x  104) of stimulator cells were employed. When optimal E:S ratios were used all strain 
combinations produced an MLC response ~20,000 cpm. The responses  were measured on day 4 of 
culture. 
TABLE  V 
Ly Phenotype of the T  Cell Proliferating in Response to MHC 1-Region 
Differences 
A.TH*  A.TL~:  [SH]TdR uptake§ 
responder  stimulator 
cpm/culture zlz SE 
No treatment  -  1,426 ± 370 
No treatment  +  28,331 ±  1,130 
Anti,Ly-l.2 + C'  -  1,324 ±  106 
Anti-Ly-l.2 + C'  +  2,724 ±  1,000 
Anti-Ly-2.2  + C'  -  1,019 ± 484 
Anti-Ly-2.2 + C'  +  24,759 ±  1,190 
1167 
* Responder cells consisted of 2.5 ×  105 nylon wool-nonadherent spleen cells. 
Stimulator cells consisted of 2.5 ×  l0  s spleen cells which received 2,000 rad 
of irradiation before culture. 
§ The response  was measured on day 4 of culture. 
>20,000  cpm  (data  not  shown).  A  difference  in either  the  K  or  D  region did  not 
appear  to  be  important because  in neither case  (H-2K  ~ [group  II];  H-2D  b  [group 
III]) was an enhanced response observed. 
Because enhancement of the  primary MLC  occurred only when I-A and/or I-B 
differences were involved, it became important to determine the Lyt phenotype of the 
proliferating cell population. Spleen cells from  A.TH mice were treated with anti- 
Lyt-l.2 or Lyt-2.2 before stimulation with A.TL spleen cells. Treatment of the spleen 
cells with anti-Lyt-1.2 resulted in a population incapable of proliferating in a primary 
MLC  (Table V).  In contrast, anti-Lyt 2.2  treatment had  no effect  on the  primary 
MLC. These results indirectly indicate that the T  cell subpopulation acted upon by 
Fc fragments bears the Lyt-l+23  -  phenotype. To directly determine this possibility 
effector cells were depleted of Lyt-1+23  -  cells before mixing with stimulator cells and 
Fc  fragments. The  results shown  in Fig.  5  demonstrate that  the  depletion of Lyt- 
l+23--bearing T  cells removes the  ability of Fc  fragments to  enhance the  I-region 
difference MLC. 
Because the D-region difference MLC was not enhanced by Fc fragments, it was 
deemed  important to  ascertain the  Lyt  phenotype of the  effector cell.  Spleen cells 
from B10.A mice were  treated with anti-Lyt-l.2 or Lyt-2.2 before stimulation with 
B10.A(2R)  spleen cells. The results in Table VI show that treatment of the effector 
population  with  either  anti-Lyt-l.2  or  anti-Lyt-2.2  reduced  the  proliferation  to 1168  Fi>MEDIATED  ENHANCEMENT  OF  T  CELL  FUNCTIONS 
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FzG. 5.  A[logeneic MLC response between ]-region-incompataible strains. The responder (A.TH) 
population was treated with anti-Lyt-l.2  +  C' before stimulation with suboptimal numbers (1  × 
104/culture) of stimulator (A.TL) cells and Fc. The response was measured on day 4 of culture. 
TABLE  VI 
Ly Phenotype of the T Cell Proliferating in Response to MHC D-Region 
Differences 
B 10.A*  B 10.A(2R):~  [aH]TdR uptake§ 
responder  stimulator 
cpm/culture +_ SE 
No treatment  -  1,493 +  294 
No treatment  +  23,040  ±  3,000 
Anti-Ly-l.2 +  C'  -  1,514 ±  146 
Anti-Ly-l.2 +  C'  +  1,650 ±  260 
Anti-Ly-2.2 +  C'  -  1,324 ±  281 
Anti-Ly-2.2 +  C'  +  1,611 ±  393 
* Responder cells consisted of 2.5 X  l0  s nylon wool-nonadherent spleen cells. 
Stimulator cells consisted of 2.5  x  105 spleen cells which received 2,000  rad 
of irradiation before culture. 
§ The response was measured on day 4 of culture. 
background levels. Moreover, when mixtures of Lyt-1+23  -  and Lyt-1-23  ÷ cells were 
used as effectors, no significant  proliferation was observed  (data not  shown).  These 
results are interpreted to mean that the cell population stimulated to proliferate in D- 
region MLC bears the Lyt-123  + phenotype. 
Discussion 
The Fc portion of mammalian Ig possesses the ability to enhance, both in vivo and 
in  vitro,  specific antibody responses  (8,  9).  Moreover, this  adjuvant  effect has been 
found to occur through the action of Fc fragments on the helper T  cell population (9). 
Evidence is presented in this report showing that T  cell-mediated responses, antigen- 
induced  proliferation, and MLC can be enhanced  by the presence of Fc fragments. 
Although  Fc fragments do not  induce T  cells to proliferate  (1),  they do activate T 
cells to release lymphokine(s). Thoman et al. (7) recently observed that in the presence 
of Fc fragments, T  cells are stimulated  to release a  soluble factor termed  (Fc)TRF. 
This factor has been  found  to replace the need  for a  T  cell signal  in  Fc fragment- 
induced polyclonal antibody production. 
The T  cells acted upon by Fc fragments in the enhancement of both the antigen- 
induced  proliferative and  MLC responses possess the phenotypic markers of helper 
cells.  The  antigen-primed  lymph  node  T  cells  which  proliferate  upon  in  vitro E. L.  MORGAN, M. L. THOMAN, AND W. O. WEIGLE  1169 
stimulation with antigen have also been shown to function as helper cells for antibody 
production as measured in a  secondary hapten-carrier system (15).  Moreover, these 
primed lymph node cells bear the Lyt-l+23  -  phenotype (15).  This observation has 
been  confirmed in this report  as anti-Lyt-l.2, but  not anti-Lyt-2.2, abrogated the 
ability of OVA-primed T  cells to proliferate in response to antigen. In addition, this 
Lyt-1+23  -  population was the cell population susceptible to the enhancing properties 
of Fc fragments. The antigen-induced proliferative response of Lyt-l+23  -  cells was 
enhanced approximately threefold compared with the controls that received antigen 
alone. 
In addition to being able to enhance antigen-induced proliferative responses, Fc 
fragments potentiated primary in vitro MLC between H-2-disparate strains of mice. 
The primary MLC could be enhanced by as much as 20-fold if a  suboptimal E:S 
ratio was employed. As previously described for enhancement of antibody responses 
(8, 9)  and antigen-induced proliferation, the optimal conditions for enhancing the 
MLC require suboptimal numbers of stimulatory cells. The maximal enhancement 
occurred with limited numbers of stimulator cells. 
Of special  importance  is  that  Fc  fragment-mediated enhancement  of MLC  is 
restricted  to  those  responses  where  the  allogenic differences between effector and 
target cells encompass the I-A and/or I-B subregions. By employing B10 congenic 
mice, it was observed that differences in I-A and/or I-B subregions were mandatory 
for obtaining an enhanced MLC. The strain combinations used to map the I-region 
differences necessary  for enhancement  contained H-2K-region differences as well. 
That the H-2K-region differences played no role in the Fcomediated enhancement 
was indicated by the fact that I-region differences (A.TH anti-A.TL) produced an 
enhanceable MLC (fourfold). These data also suggest that a  difference in the newly 
described  I-N  subregion  between  H-2K  and  I-A  (16)  is  not  responsible  for  the 
enhanced MLC, because  H-2K-region-incompatible strains did not lead to an in- 
creased proliferative response. Furthermore, the nature of the I-A- and/or I-B region 
antigenic determinant does not appear to be important because Fc fragments were 
capable  of enhancing  MLC  where  I-Ak,I-B k or  I-Ab,I-B b were  recognized  as  the 
stimulating determinants. The Lyt phenotype of the T  cells responding to I-A- and/ 
or I-B-region differences was found to be Lyt-l+23  -  whereas the nonenhanceable H- 
2D-region MLC was mediated by Lyt-123  + cells. The Lyt phenotype of the H-2D- 
region MLC effector cells was deduced from the experiments where both anti-Lyt-1.2 
and anti-Lyt-2.2 treatment reduced the anti-H-2D MLC to background levels. 
The  studies  of Cantor  and  Boyse  (17,  18)  indicate  that  the  differentiation of 
cytotoxic T  cells in vitro is associated with the collaboration of an amplifier or helper 
population  with  the  cytotoxic T  cell  precursor.  The  amplifier T  cell  population 
appears to be expressed as the proliferating cell in the primary MLC reaction. The 
recognition of I-region determinants by T cells has been associated with the production 
of helper cells for the primary cell-mediated lympholysis (CML) response by T  cells 
to H-2K- or D-region determinants (17-21). In addition, the Lyt phenotype of helper 
cells in the CML response between H-2-disparate strains is an Lyt-l+23  -  T  cell (17, 
18,  22,  23).  Taken  together  these  results  are  interpreted  to  mean  that  Lyt-l-23  + 
cytotoxic T  cell  precursors  (17,  18)  recognized  H-2K  and/or  D  antigens  and  in 
conjunction with Lyt-1+23  -  cells, which recognize I region determinants, produce the 
CML response. Exceptions to this general model exist when limited H-2 differences 1170  Fc-MEDIATED ENHANCEMENT OF T CELL FUNCTIONS 
(24-26), syngeneic tumors (27, 28), virus-modified (29), or haptenated (30) syngeneic 
cells are employed. In all these cases it appears that an Lyt-123  + amplifier or helper 
cell  is  required  for efficient expression of cytotoxicity. The work described in  this 
report employing limited H-2 differences in MLC reactions confirms that of others 
(24-26),  in  that  the  proliferating  cell  population  generated  against  H-2D-region 
differences contains  Lyt-123  +  cells.  The  reason  for the  ability of Fc  fragments  to 
potentiate MLC against I-A- and/or I-B-region, but not H-2K- or D-region differences 
is presently unknown. Because it has been proposed that Lyt-123  + cells are precursors 
ofLyt-l+23  -  and Lyt-l-23  + cells, the possibility exists that these Lyt-123  + cells are an 
immature population and  are unable to respond to the Fc signal.  This possibility 
seems unlikely in light of the work by Swain et al.  (31, 32) where they describe the 
existence of long-lived, mature Lyt-123  + helper cells. These authors  (31, 32)  found 
that helper activity for the primary in vitro response to sheep erythrocytes could be 
induced by recognition of foreign H-2 antigens. Helper activity generated with whole 
haplotype or I-re#on differences was derived from Lyt-1+23  -  cells, whereas H-2K- or 
D-region differences produced Lyt-123  + helper cells. 
The foregoing results indicate that  only certain subpopulations of helper T  cells 
(i.e., Lyt-l+23  -) are susceptible to the enhancing properties of Fc fragments. Similar 
observations have recently been found to hold true for CML responses.  Enhanced 
CML occurred where whole haplotype but not H-2K- or D-region, differences were 
employed (E. L. Morgan and W. O, Weigie, manuscript in preparation). The nature 
of the signals provided by the Fc fragments and the role of the Lyt antigens, if any, 
in the acceptance of a  signal  by the T  cells are unknown  and are currently under 
investigation. 
Summary 
Fc fragments derived from human Ig were found to be capable of enhancing T cell- 
mediated,  antigen-induced  proliferative and  mixed  lymphocyte culture  responses. 
Maximum enhancement occurred when suboptimal amounts of  antigen or suboptimal 
numbers of stimulator cells were employed. Augmentation of the allogeneic mixed 
lymphocyte culture reaction requires an I-A and/or I-B subregion difference between 
effector and stimulator cell populations. Although a significant proliferative response 
was observed with K- or D-region differences, Fc fragments were unable to enhance 
the response. The T  cell population acted upon by Fc fragments in the potentiation 
of these responses bears the Lyt-1  +23- phenotype. 
We thank Nancy Kantor for excellent  technical assistance  and Janet  Kuhns for secretarial 
expertise. 
Received  for publication 2 December 1980. 
References 
1.  Berman, M. A., and W. O. Weigle. 1977. B-lymphocyte activation by the Fc region of IgG. 
J. Exp. Med.  146"241. 
2.  Morgan, E. L., and W. O. Weigle.  1979. The requirement for adherent cells in the Fc 
fragment-induced proliferative response of murine spleen ceils.J. Exp.  Med.  150:256. 
3.  Morgan, E. L., and W. O. Weigle. 1980. Regulation of Fc fragment-induced murine spleen 
cell proliferation.J. Exp. Med.  151:1. E.L.  MORGAN,  M.  L. THOMAN, AND W.  O.  WEIGLE  1171 
4.  Morgan, E. L., and W. O. Weigle. 1980. Polyclonal activation of murine B-lymphocytes by 
Fc  fragments.  I.  The  requirement  for two  signals  in  the  generation  of the  polyclonal 
antibody response induced by Fc fragments.,]. Immunol. 124:1330. 
5.  Morgan,  E.  L.,  and  W.  O.  Weigle.  Regulation  of B-lymphocyte activation  by the  Fc 
portion of immunoglobulin.J. Supramol. Struct. In press. 
6.  Thoman, M. L., E. L. Morgan, and W. O. Weigle.  1980. Polyclonal activation of murine 
B lymphocytes by Fc fragments.  II. Replacement of T  cells  by a  soluble  helper T  cell- 
replacing factor CFRF). J. Irnmunot. 125:1630. 
7.  Thoman,  M.  L.,  E.  L.  Morgan, and W. O. Weigle.  1981. Fc fragment  activation of T 
lymphocytes. I. Fc Fragments trigger Lyt 1+23  -  T  lymphocytes to release a helper T  cell 
replacing activity. J. Immunol. 123:632. 
8.  Morgan, E. L., S. M. Walker, M. L. Thoman, and W. O. Weigle.  1980. Regulation of the 
immune response.  I. The potentiation  of in vivo and  in vitro immune responses by Fc 
fragments.,]. Exp. Med.  152:113. 
9.  Morgan, E. L., M. L. Thoman, S. M. Walker, and W. O. Weigle.  1980. Regulation of the 
immune response. II. Characterization of  the cell population(s) involved in the Fc fragment- 
induced adjuvant effect. J. Immunol. 125:1275. 
10.  Porter,  R.  R.  1959. The hydrolysis of rabbit  y-globulin and antibodies  with crystalline 
papain. Biochem. J. 43:119. 
11.  Spiegelberg, H. L.  1976.  Principle of methods. In Textbook of Immunopathology. P. A. 
Miescher and H. J. Mueller, editors. Grune & Stratton, Inc., New York. 101. 
12.  Julius, M. H., E. Simpson, and L. A. Herzenberg.  1973. A rapid method for the isolation 
of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3:645. 
13.  Shen,  F.-W.,  E.  A.  Boyse, and  H.  Cantor.  1975. Preparation  and  use  of Ly antisera. 
Immunogenetics. 2:591. 
14.  Corradin, G., H. M. Etlinger, and J. M. Chiller.  1977. Lymphocyte specificity to protein 
antigens. I. Characterization of the antigen-induced in vitro T  cell-dependent proliferative 
response with lymph node cells from primed mice. J. Immunol. 119:1048. 
15.  Schrier, R. D., B. J.  Skidmore, J. T. Kumick, S.  N. Goldstine, and J.  M. Chiller.  1979. 
Propagation of antigen-specific T cell helper function in vitro.  J. Iramunol. 123:2525. 
16.  Hayes, C. E., and F. H. Bach. 1980. I-N. A newly described H-2 1 subregion between K and 
I-A. J. Exp. Med.  151:481. 
17.  Cantor, H., and E. A. Boyse. 1975. Functional subclasses ofT lymphocytes bearing different 
Ly antigens. I. The generation of functionally distinct T-cell subclasses  is a differentiative 
process independent of antigen.J. Exp. Med.  141:1376. 
18.  Cantor, H., and E. A. Boyse. 1975. Functional subclasses ofT lymphocytes bearing different 
Ly antigens.  II. Cooperation between  subclasses  of Ly  + cells  in the generation of killer 
activity..]. Exp. Ailed. 141:1390. 
19.  Wagner, H., D. G6tze, L. Ptschelinzew, and M. R/Jllinghoff.  1975. Induction of cytotoxic 
T  lymphocytes against/-region-coded determinants: in vitro evidence for a third histocom- 
patibility locus in the mouse.J. Exp. Med.  142:1477. 
20.  Alter,  B. J.,  and  F.  H.  Bach.  1974.  Role of H-2 lymphocyte-defined and  serologically- 
defined components in the generation of cytotoxic lymphocytes.  J. Exp. Med.  140:.  1410. 
21.  Bach,  F.  H.,  M.  L.  Bach,  and  P.  M.  Sondel.  1976.  Differential  function  of major 
histocompatibility complex antigens in T-lymphocyte activation. Nature (Lond.).  259:.273. 
22.  Wagner,  H.,  and  M.  R~illinghoff.  1978.  T-T-cell  interactions  during in  vitro cytotoxic 
allograft responses.  I. Soluble products from activated Lyl + T  cells trigger autonomously 
antigen-primed Ly23  + T  cells to cell proliferation and cytolytic activity. J. Exp.  Med.  148: 
1523. 
23.  Okada, M., G. R. Klimpel, R. C. Kuppers, and C. S. Henney. 1979. The differentiation of 1172  Fc-MEDIATED ENHANCEMENT  OF T  CELL FUNCTIONS 
cytotoxic T  cells in vitro. I. Amplifying factor(s)  in  the primary response is Lyt  1  + cell 
dependent.J. Immunol. 122:2527. 
24.  Wettstein, P. J.,  D. W. Bailey, L. E. Mobraaten, J.  Klein, and J. A. Frelinger. 1978. T- 
lymphocyte response to H-2 mutants. I. Proliferation is dependent on Ly 1+2  + cells.J. Exp. 
Med.  147:1395. 
25.  Okada, M., and C.  S. Henncy.  1980.  The differentiation of cytotoxic T  cells in vitro. II. 
Amplifying factor(s) produced in primary mixed lymphocyte cultures against K/O stimuli 
require the presence of Lyt 2  + cells but not Lyt 1  + cells.J. Immunol. 125:300. 
26.  Bach, F. H., and B. J. Alter.  1978. Alternative pathways of T  lymphocyte activation. J. 
Exp.  Med. 148:829. 
27.  Shiku, H., T. Takahasi, M. A. Bean, L. J. Old, and H. F. Oettgen.  1976. Ly phenotype of 
cytotoxic T  cells for syngeneic tumor.J. Exp. Med.  144:1116. 
28.  Stutman, O., F. W. Shen, and E. A. Boyse.  1977. Ly phenotype of T  cells cytotoxic for 
syngeneic mouse mammary tumors: evidence for T  cell interactions. Proc. Natl.  Acad. Sci. 
U. S. A. 74:5667. 
29.  Pang, T., I. F. C. McKenzie, and R. V. Blanden. 1976. Cooperation between mouse T cell 
subpopulations in the cell-mediated response to a natural pox virus. Cell. Immunol. 26:567. 
30.  Cantor, H., and E. A. Boyse. 1976. Regulation of cellular and humoral responses by T cell 
subclasses. Cold Spring Harbor Syrup. Quant. Biol. 41:23. 
31.  Swain, S. L., and P. R. Panfili. 1979. Helper cells activated by allogeneic H-2K or H-2D 
differences have a Ly phenotype distinct from those responsive to I differences. J. Immunol. 
122:383. 
32.  Swain, S. L., A. Bakke, M. English, and R. W. Dutton.  1979. Ly phenotypes and MHC 
recognition: the allohelper that recognizes K or D is a mature Ly 123 cell.,]. Immunol. 123: 
2716. 